The prevalence and degree of aPC-r does not seem to differ between patients with primary or secondary APS and patients with SLE even without circulating aPL or a history of clinical manifestations of APS (36, 37, 42, 48). The gene discussed is FASLG; the disease is autoimmune polyendocrinopathy.